Roche Ignores 80,000 Adverse Reaction Complaints And 15,000 Death Reports

- Roche, Genentech overlook 80,000 adverse reaction complaints (FiercePharma, June 21, 2012): Regulators visiting a Roche ($RHHBY) facility in the U.K. found a surprise lurking in the company’s computer system: 80,000 uninvestigated adverse reaction reports from the U.S. The reports are on a hodgepodge of drugs made by the Swiss company and include more than [...] continue reading latest news